Staging systems for predicting survival of patients with hepatocellular carcinoma after surgery

Table 3 Overall survival rates of hepatocellular carcinoma patients according to their tumor stage

Tumor stage	n	Survival rate (%)
		1-yr	3-yr	5-yr
CS
I	132	0.916	0.760	0.693
II	265	0.622	0.426	0.281
III	41	0.330	0.126	0.126
TNM
I	271	0.825	0.652	0.548
II	67	0.521	0.354	0.216
III	82	0.437	0.235	0.153
IV	18	0.278	/	/
BCLC
A	178	0.870	0.678	0.602
B	165	0.756	0.574	0.402
C	95	0.375	0.182	0.142

CS: Chinese staging; TNM: Tumor node metastasis; BCLC: Barcelona clinic liver cancer.